Search research articles
Contact Us
Filters
Showing results (241-250 of 259) with videos related to
Page
of 26
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 27, 2018
Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial
Thomas Ruhstaller, Anita Giobbie-Hurder, Marco Colleoni, et al.
Journal of the National Cancer Institute
|
July 5, 2022
Predictive Role of CD36 Expression in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Trastuzumab
Francesca Ligorio, Serena Di Cosimo, Paolo Verderio, et al.
European Journal of Heart Failure
|
December 21, 2010
Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology
Thomas Eschenhagen, Thomas Force, Michael S Ewer, et al.
JACC. Cardiooncology
|
February 19, 2025
Cardiovascular Safety in Oncology Clinical Trials: JACC: CardioOncology Primer
Marc P Bonaca, Ninian N Lang, Alice Chen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 25, 2021
Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D)
Alvaro Moreno-Aspitia, Eileen M Holmes, Christian Jackisch, et al.
The Lancet. Oncology
|
January 2, 2021
Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox
Peter Dubsky, Katja Pinker, Fatima Cardoso, et al.
Nature Communications
|
November 3, 2023
Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial
Laurence Buisseret, Delphine Loirat, Philippe Aftimos, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 13, 2025
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitors
Evert S M van Aken, Ajeet Kumar Gandhi, Sean M O'Cathail, et al.
NPJ Precision Oncology
|
March 11, 2025
A nationwide comprehensive genomic profiling and molecular tumor board platform for patients with advanced cancer
Pieter-Jan Volders, Philippe Aftimos, Franceska Dedeurwaerdere, et al.
European Journal of Heart Failure
|
December 7, 2023
European Society of Cardiology Core Curriculum for cardio-oncology
Teresa López-Fernández, Dimitrios Farmakis, Pietro Ameri, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 259) with videos related to
Sort By:
Page
of 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 27, 2018
Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial
Thomas Ruhstaller, Anita Giobbie-Hurder, Marco Colleoni, et al.
Journal of the National Cancer Institute
|
July 5, 2022
Predictive Role of CD36 Expression in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Trastuzumab
Francesca Ligorio, Serena Di Cosimo, Paolo Verderio, et al.
European Journal of Heart Failure
|
December 21, 2010
Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology
Thomas Eschenhagen, Thomas Force, Michael S Ewer, et al.
JACC. Cardiooncology
|
February 19, 2025
Cardiovascular Safety in Oncology Clinical Trials: JACC: CardioOncology Primer
Marc P Bonaca, Ninian N Lang, Alice Chen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 25, 2021
Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D)
Alvaro Moreno-Aspitia, Eileen M Holmes, Christian Jackisch, et al.
The Lancet. Oncology
|
January 2, 2021
Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox
Peter Dubsky, Katja Pinker, Fatima Cardoso, et al.
Nature Communications
|
November 3, 2023
Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial
Laurence Buisseret, Delphine Loirat, Philippe Aftimos, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 13, 2025
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitors
Evert S M van Aken, Ajeet Kumar Gandhi, Sean M O'Cathail, et al.
NPJ Precision Oncology
|
March 11, 2025
A nationwide comprehensive genomic profiling and molecular tumor board platform for patients with advanced cancer
Pieter-Jan Volders, Philippe Aftimos, Franceska Dedeurwaerdere, et al.
European Journal of Heart Failure
|
December 7, 2023
European Society of Cardiology Core Curriculum for cardio-oncology
Teresa López-Fernández, Dimitrios Farmakis, Pietro Ameri, et al.
Page
of 26